NWe performed an openlabel, singlearm phase II study of vorinostat in
NWe performed an openlabel, singlearm phase II study of vorinostat in patients with relapsedrefractory indolent BNHL and MCL. The ORR and median PFS values in relapsedrefractory FL ( and months…